A newly discovered gene combined with an already known genetic factor could explain the risk of skin side effects in more ...
The ExacTcell™ platform utilizes advanced immunological screening as well as laboratory testing to identify key targets recognized by the immune system across different HLA types. With this expanded ...
A recent study discovered that a new gene test may assist predict which gout patients could suffer dangerous skin reactions ...
ProImmune has announced the launch of its ProVE SL Self-Loading MHC Class I Monomers, a new reagent platform designed to enhance antigen-specific CD8+ T cell detection. The Oxford-based life science ...
ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE(R) SL Self-Loading MHC Class I Monomers. The novel reagents for antigen-specific CD8+ ...
The Irrawaddy highlights the junta-aligned candidates contesting Myanmar’s December polls, illustrated in a series of state ...
TREOS Bio today announced the publication in Journal of Clinical Oncology - Oncology Advances of results from OBERTO-201 (NCT05130060), a Phase 1b study evaluating PolyPEPI1018, an off-the-shelf multi ...
Dr. Kai Wang and his team published a review in Life Medicine to summarize the iPSC modification strategies to reach immune ...
Based on these data, iSCIB1+ has been selected for future development expanding the addressable patients to around 80% of late-stage melanoma patients and with longer patent life. Development plans ...
Scancell Holdings reported strong phase two results for its Immunobody iSCIB1+ cancer immunotherapy on Friday, showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback